273 related articles for article (PubMed ID: 24448358)
1. Prognostic value of microRNA expression in operable non-small cell lung cancer patients.
Skrzypski M; Czapiewski P; Goryca K; Jassem E; Wyrwicz L; Pawłowski R; Rzyman W; Biernat W; Jassem J
Br J Cancer; 2014 Feb; 110(4):991-1000. PubMed ID: 24448358
[TBL] [Abstract][Full Text] [Related]
2. MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.
Patnaik S; Mallick R; Kannisto E; Sharma R; Bshara W; Yendamuri S; Dhillon SS
J Thorac Oncol; 2015 Mar; 10(3):446-53. PubMed ID: 25695220
[TBL] [Abstract][Full Text] [Related]
3. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients.
Kaduthanam S; Gade S; Meister M; Brase JC; Johannes M; Dienemann H; Warth A; Schnabel PA; Herth FJ; Sültmann H; Muley T; Kuner R
Lung Cancer; 2013 May; 80(2):223-7. PubMed ID: 23410826
[TBL] [Abstract][Full Text] [Related]
5. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
Zhang YK; Zhu WY; He JY; Chen DD; Huang YY; Le HB; Liu XG
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1641-50. PubMed ID: 22618509
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
Lu Y; Govindan R; Wang L; Liu PY; Goodgame B; Wen W; Sezhiyan A; Pfeifer J; Li YF; Hua X; Wang Y; Yang P; You M
Carcinogenesis; 2012 May; 33(5):1046-54. PubMed ID: 22331473
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
8. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
13. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
[TBL] [Abstract][Full Text] [Related]
14. A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.
Campayo M; Navarro A; Viñolas N; Tejero R; Muñoz C; Diaz T; Marrades R; Cabanas ML; Gimferrer JM; Gascon P; Ramirez J; Monzo M
PLoS One; 2011; 6(7):e22509. PubMed ID: 21799879
[TBL] [Abstract][Full Text] [Related]
15. miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.
Tejero R; Navarro A; Campayo M; Viñolas N; Marrades RM; Cordeiro A; Ruíz-Martínez M; Santasusagna S; Molins L; Ramirez J; Monzó M
PLoS One; 2014; 9(7):e101899. PubMed ID: 25003366
[TBL] [Abstract][Full Text] [Related]
16. Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing.
Ma J; Mannoor K; Gao L; Tan A; Guarnera MA; Zhan M; Shetty A; Stass SA; Xing L; Jiang F
Mol Oncol; 2014 Oct; 8(7):1208-19. PubMed ID: 24785186
[TBL] [Abstract][Full Text] [Related]
17. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
18. Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
Sim J; Kim Y; Kim H; Shin SJ; Kim DH; Paik SS; Jang K
Medicine (Baltimore); 2018 Jun; 97(25):e10996. PubMed ID: 29923982
[TBL] [Abstract][Full Text] [Related]
19. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
